I-Vitamin B17 igama eliqhelekileyo elisetyenziselwa ikhemikhali ebizwa ngokuba yi-amygdalin. Ngokuqhelekileyo zixutywe kwiifomthi ze-apricot kunye nama-alimondi abukrakra, i-amygdalin isetyenziselwa ukwenza i-laetrile (isicatshulwa sathi sinceda kunyango lomhlaza). Nangona bahlala bebizwa ngokuthi "i-vitamin B17," akukho amygdalin okanye i-laetrile ngokwenene i-vitamin B.
Ukusetyenziswa kweVithamini B17
Ngokuqhelekileyo uLaetrile ufunwa ukuba uphathe umhlaza ngokwasemvelo.
Ayivunyelwanga yi-US Food and Drug Administration njengonyango lomhlaza, okanye nayiphina imeko yonyango.
Abanye abaxhasa i-laetrile bakhombisa ukuba umdlavuza uvela ngenxa ye-vitamin deficiency. Abaxhasi banjalo bathi ukusetyenziswa kwe-vitamin B17 kuthiwa kunokuphelisa ukusilela, kunye nokuncedisa unyango okanye ukukhusela umhlaza. Nangona kunjalo, njengoko iNational Cancer Institute (NCI) ithi, akukho bungqina bokuba i-laetrile iyadingeka ngumzimba okanye ukuba i-laetrile inokusebenza njengevithamini kwizilwanyana okanye kubantu.
I-Laetrile iphinda ifune ukukhusela kwiimeko ezifana nokunyuka kwegazi kunye ne- arthritis .
Imithombo yeVithamini B17
U-Amygdalin ufunyanwa ngokwemvelo kwiinki eziluhlaza kunye nemigodi yeziqhamo ezininzi. Kukho kwakhona kwizityalo ezinjengobhontshisi bama-lima, i-clover, ne-sorghum.
Iimpawu eziPhezulu kunye nezoKhuseleko
U-Amygdalin uvelisa i-cyanide, into eyingozi. I-Cyanide icatshangelwa ukuba yintloko ye-cancer ye-laetrile kunye ne-amygdalin.
Kuthiwa ukuba i-cyanide ikhutshwe emzimbeni ngala mazwi angayibulala amaseli omhlaza.
Ephuhliswe eUnited States kuma-1950, i-laetrile ibingelwa ukuba ibe yindlela engcolileyo ye-amygdalin. Sekunjalo, i-laetrile ifunyenwe ukudala uluhlu lweempembelelo ezinjengezo ze-cyanide.
Ukusetyenziswa kwe-laetrile kuhambelana neziphumo ezilandelayo: umbala okwesibhakabhaka ulusu, ukudideka, ukuhamba kanzima, ukungcola, ukunyuka kweentloko zeentloko, intloko yesifo, umonakalo wesibindi, uxinzelelo lwegazi oluphantsi, isisonguluko, umonakalo weentlanzi kunye nokuhlanza. Utyhefu lwe-Cyanide luya kusongela ubomi kwaye lunokubangela ukufa.
Ngokutsho kwe-NCI, ukusetyenziswa kwe-laetrile kudibaniswa nomngcipheko ophezulu we-coma okanye ukufa.
Kukho inkxalabo yokuba i-vitamin C inokunyusa inani le-cyanide ekhishwe kwi-laetrile emzimbeni kwaye, ngenxa yoko, ibangela umngcipheko wokwanda kwesifo sotywala.
Uphando ngeVithamini B17
Amabango athi i-laetrile okanye i-amygdalin ingazuza izigulane zomhlaza azixhaswanga ngedatha echanekileyo yekliniki, ngokwembiko eshicilelwe kwiDatabase ye - Cochrane yeeNkqubo zoVavanyo ngo-2011.
Kule ngxelo, izazinzulu ziye zahlalutya iimvavanyo ezingama-69 ezipapashwe ngaphambili ezichazwe kwimiphumo echasene nomhlaza kunye nemiphumo emibi ye-laetrile kunye ne-amygdalin. Nangona kunjalo, akukho nanye kwezi zifundo ezifunyenwe ukuba zanele ngokukhawuleza ukuba zihlangabezane neenqobo zokuhlaziywa kwabathengi.
Ekugqibeleni kwabo, abalobi babika ukuba ukusetyenziswa kwe-laetrile okanye i-amygdalin inomngcipheko omkhulu wemiphumo emibi ebangelwa yi-cyanide yetyhefu.
Ngaloo nto, abalobi bathi isigxina-mngcipheko we-laetrile okanye i-amygdalin njengonyango lomhlaza ngenxa yoko ayikho into engathandekiyo. "
Kwiminyaka emininzi yophando eshicilelwe kwiminyaka yamuva, abaphandi baye baqaphela ukuba i-amygdalin inokuthi ibe neepropati zokulwa nomhlaza.
Uphando olupapashwe kwi- Immunopharmacology ne-Immunotoxicology ngo-2013, umzekelo, lubonisa ukuba i-amygdalin ingakhusela umhlaza wesibeleko. Kwiimvavanyo zeseli zomntu, abaphandi bathi i-amygdalin inokulwa nomhlaza wesibeleko ngokunyusa i-apoptosis (uhlobo lwesifo sokufa esicwangcisiweyo kubalulekile ukunqanda ukusabalala kweeseli zomhlaza).
Ukongezelela, izifundo ezimbini zokuqala ezipapashwe kwi- PLoS One ngo-2014 zifumene ukuba i-amygdalin inokulwa nomhlaza wesisu, inxalenye ngokukhusela ukukhula komzimba.
Uphando olongezelelweyo lufunekayo ngaphambi kokuba i-amygdalin inokucetyiswa ukuthintela okanye unyango lomhlaza.
Eminye i-Vitamin B17
Nangona kungekho ndlela eyaziwayo yokuthintela umdlavuza, iindlela ezithile zinganceda ukunciphisa ingozi yomhlaza wakho. Ezi zinto ziquka ukunqanda ukutshaya nokusetyenziswa kwecuba, ukuhlolwa kweemeko ezinqabileyo, ukulandela ukutya okunempilo, ukuqhuba rhoqo, nokugcina ubunzima obuphilileyo .
Ukuba ucinga ukusebenzisa i-vitamin B17 ekuthintelo okanye unyango lomhlaza, kubalulekile ukudibana nodokotela wakho kuqala. Ukuziphatheka nokukhusela okanye ukulibazisa ukunakekelwa okuqhelekileyo kunokuba nemiphumo emibi.
> Imithombo:
> I-Y, i-J, i-Wang F, i-Hu J, i-Cui A, i-Wei C, i-Yang Q, i-Li F. "U-Amygdalin uhlawula i-Apoptosis kwi-Cell Cervical Cancer Cell Line I-HeLa Cells." Immunopharmacol Immunotoxicol. 2013 Feb; 35 (1): 43-51.
> Makarević J, Rutz J, Juengel E, Kaulfuss S, Reiter M, Tsaur I, Bartsch G, Haferkamp A, Blaheta RA. "I-Amygdalin Iibhloko zeCarry Cancer Cell Growth In Vitro ngokuNciphisa i-Cyclin A kunye ne-cdk2." PLoS One. 2014 u-Agasti 19; 9 (8): e105590.
> Makarević J, Rutz J, Juengel E, Kaulfuss S, Tsaur I, Nelson K, Pfitzenmaier J, Haferkamp A, Blaheta RA1. Iimpembelelo zika-Amygdalin I-Cancer Cell Adhesion and Invasion in Vitro. " PLoS One. 2014 Okthoba 15; 9 (10): e110244.
> Milazzo S, Ernst E, Lejeune S, Boehm K, Horneber M. "Laetrile Treatment for Cancer." I-Cochrane Database Syst Rev. 2011 Nov 9; (11): CD005476.
> Milazzo S, Lejeune S, Ernst E. "I-Laetrile yeCarcer: uVavanyo oluHlolo lweeNkcazo zeCliniki." Inkxaso yeCancer Care. 2007 Juni; 15 (6): 583-95.
> INational Cancer Institute. "Laetrile / Amygdalin (PDQ) -Indinyana yePatient." Juni 2015.
> Ingoma Z, Xu X. "Uphando oluphambili kwi-Anti-tumor Impact of Amygdalin." J Cancer Res Ther. U-Agasti wama-2014; iSiza 1: 3-7.